Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Vet Parasitol ; 112(1-2): 33-50, 2003 Feb 28.
Article in English | MEDLINE | ID: mdl-12581583

ABSTRACT

The objective of this study was to confirm the presence of seven species of Eimeria involved in chicken coccidiosis in Australia by comparing internal transcribed spacer 1 (ITS-1) sequences, ITS-1 polymerase chain reaction (PCR) methods and to apply phylogenetic analysis to assess evolutionary relationships of Australian isolates. Twenty-two distinct ITS-1 regions of 15 Australian Eimeria isolates were sequenced, and analysed using maximum parsimony, distance and maximum likelihood methods. Poor bootstrap support, resulting from high ITS-1 sequence heterogeneity between all species groups, resulted in polychotomy of the Eimeria species in all three trees generated by these analyses. Percentage identity analyses revealed two distant ITS-1 lineages in both E. mitis and E. maxima at the same levels that separate the two species E. tenella and E. necatrix. One E. maxima lineage consisted of Australian isolates, the other American isolates, with one European sequence (originating from the same isolate) in each lineage. One Australian E. praecox sequence was only distantly related (33% variation) to three E. praecox sequences from Australian and European isolates. Short and long ITS-1 variants were isolated from both E. tenella (cloned line) and E. necatrix isolates with deletions (106 and 73 bp, respectively) in the short variants within the 3' region of the ITS-1 sequence. ITS-1 sequences of strains of both E. brunetti and E. acervulina species varied the least. Apart from E. maxima, all of the ITS-1 sequences of the six remaining individual species clustered to the exclusion of other species in all phylogenetic trees. Published ITS-1 tests for E. necatrix, E. acervulina, E. brunetti and E. tenella, combined with three new tests for E. mitis, E. praecox and Australian E. maxima amplified all respective Australian isolates specifically in a nested format using conserved ITS-1 PCR products as template to improve the sensitivity. All PCR tests were confirmed against a collection of 24 Australian chicken Eimeria isolates and contaminating species were detected in some instances. In conclusion, once the genetic variation between species and strains is determined, the ITS-1 is a good target for the development of species-specific assays, but the ITS-1 sequences alone do not seem suitable for the confirmation of phylogenetic inferences for these species. This study reports the first attempt at the analysis of the phylogeny and sequence comparison of the Eimeria species involved in chicken coccidiosis in Australia.


Subject(s)
Chickens/parasitology , DNA, Intergenic/genetics , Eimeria/classification , Eimeria/genetics , Genetic Variation , Animals , Australia , Base Sequence , Coccidiosis/veterinary , DNA, Intergenic/analysis , DNA, Protozoan/genetics , Eimeria/isolation & purification , Evolution, Molecular , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , Poultry Diseases/diagnosis , Poultry Diseases/parasitology , Sequence Homology, Nucleic Acid , Species Specificity
2.
Vet Microbiol ; 86(4): 325-35, 2002 May 24.
Article in English | MEDLINE | ID: mdl-11955782

ABSTRACT

Anaplasma marginale is the causative agent of bovine anaplasmosis, a disease which can be protected by vaccination with the less pathogenic Anaplasma species, A. centrale. Currently, there is no polymerase chain reaction (PCR) assay available which differentiates between different species of Anaplasma or which can differentiate isolates of A. marginale within outbreaks and between different countries. A molecular test specific for A. marginale would be ideal for the identification of Anaplasma species in wild ruminants, as possible reservoirs of anaplasmosis, and to differentiate between A. marginale from A. centrale. A PCR assay was designed to amplify the major surface protein 1alpha gene of the rickettsial bovine pathogen, A. marginale both as an inter- and intra-specific test. The test did not amplify A. centrale or A. ovis, and discriminated A. marginale by amplifying repeat regions within the msp1alpha gene which vary in number between many isolates. The nested A. marginale amplicons varied in size from 630 to 1190bp representing one to eight internal repeats. All 22 Australian isolates tested amplified a 630bp product (one repeat) in contrast to all 19 non-Australian isolates tested. Eight sequences from Australian isolates from different geographical regions confirmed the conserved nature of the Australian A. marginale msp1alpha genes. The Australian 'repeat unit' MSP1a deduced amino acid sequence has been designated as Australian type 1. The msp1alpha PCR method developed here enabled the amplification and comparison of A. marginale isolates originating from North and South America, Africa, Israel and Australia. The method is sensitive and specific for A. marginale. Although additional msp1alpha products were amplified from at least two Australian isolates, the results suggest limited introduction of A. marginale into Australia.


Subject(s)
Anaplasma/genetics , Anaplasmosis/diagnosis , Bacterial Outer Membrane Proteins/genetics , Cattle Diseases/diagnosis , Amino Acid Sequence , Anaplasma/classification , Animals , Bacterial Outer Membrane Proteins/chemistry , Cattle , Cattle Diseases/microbiology , Diagnosis, Differential , Geography , Molecular Sequence Data , Molecular Weight , Phylogeny , Polymerase Chain Reaction/veterinary , Sensitivity and Specificity , Species Specificity , Tandem Repeat Sequences
3.
Aust Vet J ; 78(3): 179-81, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10860157

ABSTRACT

OBJECTIVE: To demonstrate the value of PCR assays to determine the genotypes of Babesia bovis in cattle with clinical signs of babesiosis within 3 weeks after vaccination against tick fever. DESIGN: Samples from 5 cases of babesiosis in cattle soon after vaccination against tick fever were analysed in two PCR assays. PROCEDURE: Parasite DNA was purified from blood taken from cattle with signs of babesiosis within 3 weeks of vaccination against tick fever. DNA was also prepared from the tissues of animals that died of babesiosis. Two PCR assays that amplify repeat sequences of DNA within the B bovis genes, Bv80 and BvVA1, were used to differentiate the genotypes of field isolates and vaccine strains of B bovis. RESULTS: One of the five cases of babesiosis was found to be caused by a vaccine strain, but PCR analyses showed that the predominant isolate in the other four cases was not the vaccine strain. CONCLUSIONS: PCR assays on the DNA of B bovis obtained from the blood or tissues of cattle clinically affected with tick fever within 3 weeks after vaccination are useful to distinguish between vaccine strains and field isolates as the source of infection.


Subject(s)
Babesia bovis/classification , Babesiosis/parasitology , Cattle Diseases/parasitology , DNA, Protozoan/blood , Protozoan Vaccines/adverse effects , Tick-Borne Diseases/prevention & control , Animals , Babesia bovis/genetics , Babesia bovis/immunology , Babesiosis/etiology , Cattle , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Genotype , Male , Polymerase Chain Reaction/veterinary , Predictive Value of Tests , Vaccines, Attenuated/adverse effects
4.
Avian Dis ; 42(1): 119-23, 1998.
Article in English | MEDLINE | ID: mdl-9533088

ABSTRACT

A polymerase chain reaction (PCR)-based assay was developed for the detection of Eimeria acervulina. Primers were designed to amplify a fragment of the EASZ240/160 sporozoite antigen gene. The PCR assay detected as few as 10 E. acervulina oocysts in a mixed population containing a total of 10(6) oocysts. No nonspecific reaction was observed with any other species of avian Eimeria known to occur in Australia. PCR products from genomic DNA were 237 bp larger than predicted from previously reported cDNA sequences. Sequencing of the product revealed the presence of a probable intron. This work demonstrates the potential of PCR-based assays for identification and detection of avian Eimeria. Potential uses include identification of minor species present in mixed infections and quality control in the production of live vaccines.


Subject(s)
Coccidiosis/veterinary , Eimeria/isolation & purification , Polymerase Chain Reaction/methods , Poultry Diseases , Animals , Australia , Chickens , Coccidiosis/diagnosis , DNA Primers , DNA, Protozoan/isolation & purification , Eimeria/classification , Eimeria/genetics , Introns , Polymerase Chain Reaction/veterinary , Sensitivity and Specificity
5.
Aust Vet J ; 75(8): 575-8, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9293339

ABSTRACT

OBJECTIVE: To determine whether particular genotypes of Babesia bovis were common to field isolates obtained from cattle properties in Queensland where the B bovis vaccine had apparently failed. DESIGN: A comparative study of polymerase chain reaction genotypes in different populations of B bovis. PROCEDURE: Two polymerase chain reaction assays were applied to analyse DNA extracts of B bovis vaccine (K, T and Dixie strains) and 27 field isolates from 24 properties where disease outbreaks had occurred despite the use of the vaccine. To evaluate the stability of the genotypes identified, 11 of the field isolates were inoculated into experimental cattle that had either been previously vaccinated with T strain or not vaccinated. RESULTS: No particular genotype of B bovis was responsible for the problems observed in previously vaccinated herds. None of the isolates had genotypes identical to the vaccine strains used. No geographic trends among the genotypes were observed. Isolates that originated from the same property also had different genotypes. Blood passage of the 11 field isolates in either previously vaccinated or nonvaccinated cattle did not alter the original genotype. CONCLUSION: No particular genotypes identified by the Bv80 and BvVA1 polymerase chain reaction assays could be associated with vaccine failures.


Subject(s)
Babesia bovis/genetics , Babesia bovis/isolation & purification , Babesiosis/parasitology , Cattle Diseases/parasitology , Genetic Variation , Protozoan Vaccines , Animals , Antibodies, Protozoan/immunology , Babesia bovis/immunology , Babesiosis/epidemiology , Babesiosis/prevention & control , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/prevention & control , DNA, Protozoan/analysis , DNA, Protozoan/genetics , Genotype , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/veterinary , Protozoan Vaccines/administration & dosage , Protozoan Vaccines/immunology , Queensland/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL